SYNGAP1 mutations: Clinical, genetic, and pathophysiological features

Research output: Contribution to journalReview articlepeer-review

Abstract

SYNGAP1 is a gene that encodes the cytosolic protein SYNGAP1 (SYNaptic GTPase Activating Protein), an essential component of the postsynaptic density at excitatory glutamatergic neurons. SYNGAP1 plays critical roles in synaptic development, structure, function, and plasticity. Mutations in SYNGAP1 result in a neurodevelopmental disorder termed Mental retardation-type 5 (MRD5, OMIM #612621) with a phenotype consisting of intellectual disability, motor impairments, and epilepsy, attesting to the importance of this protein for normal brain development. Here we review the clinical and pathophysiological aspects of SYNGAP1 mutations with a focus on their effect on synaptogenesis, neural circuit function, and cellular plasticity. We conclude by comparing the molecular pathogenesis of SYNGAP1 mutations with those of another neurodevelopmental disorder that affects dendritic function and cellular plasticity, fragile X syndrome. Insights into the molecular similarities and differences underlying these disorders could lead to rationale therapy development.

Original languageEnglish (US)
Pages (from-to)65-76
Number of pages12
JournalInternational Journal of Developmental Neuroscience
Volume78
DOIs
StatePublished - Nov 2019

Keywords

  • Epilepsy
  • Fragile X syndrome
  • Intellectual disability
  • Plasticity
  • SYNGAP1
  • Synapse

ASJC Scopus subject areas

  • Developmental Neuroscience
  • Developmental Biology

Fingerprint

Dive into the research topics of 'SYNGAP1 mutations: Clinical, genetic, and pathophysiological features'. Together they form a unique fingerprint.

Cite this